JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.00113-07v1
45/6/1838    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreoletti, L.
Right arrow Articles by Belec, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreoletti, L.
Right arrow Articles by Belec, L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2007, p. 1838-1842, Vol. 45, No. 6
0095-1137/07/$08.00+0     doi:10.1128/JCM.00113-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Genetic and Phenotypic Features of Blood and Genital Viral Populations of Clinically Asymptomatic and Antiretroviral-Treatment-Naive Clade A Human Immunodeficiency Virus Type 1-Infected Women{triangledown}

Laurent Andreoletti,1* Katharina Skrabal,2 Virginie Perrin,2 Nicolas Chomont,3 Sentob Saragosti,2 Gerard Gresenguet,4 Helene Moret,1 Jerome Jacques,1 Jean de Dieu Longo,4 Mathieu Matta,3 Fabrizio Mammano,2 and Laurent Belec3

Laboratoire de Virologie Médicale, Hôpital Robert Debré, Centre Hospitalo-Universitaire de Reims, et Equipe d'Accueil 3798, Faculté de Médecine de Reims, France,1 INSERM U552-Recherche Antivirale, Hôpital Bichat-Claude Bernard, Paris, France,2 Unité Immunité et Biothérapie Muqueuse, Centre de Recherches Biomédicales des Cordeliers, Université René Descartes (Paris V), Paris, France,3 Unité de Recherche et d'Intervention sur les Maladies Sexuellement Transmissibles et le SIDA, Faculté des Sciences de la Santé, and Centre National de Référence des Maladies Sexuellement Transmissibles et du SIDA, Bangui, République Centrafricaine4

Received 16 January 2007/ Returned for modification 4 March 2007/ Accepted 16 April 2007

In the present study, we assessed whether human immunodeficiency virus type 1 (HIV-1) genetic compartmentalization was associated with phenotypic CCR5 (R5) or CXCR4 (X4) coreceptor usage differences between the systemic and the genital viral populations. Four clinically asymptomatic and treatment-naïve clade A HIV-1-infected patients were selected from a cohort of 274 African women, because they were free of all the biological cofactors known to modify the kinetics of viral production in the genital tract. HIV RNA envelope sequences (V1 to V3) derived from plasma and cervicovaginal secretions (CVS) were amplified, subcloned, and sequenced. CCR5 or CXCR4 coreceptor usage was determined by production of recombinant viral particles, followed by single-cycle infection assays of indicator cell lines, using the tropism recombinant test. In these four selected patients, CVS-derived sequences appeared to be genetically distinct from blood-derived sequences (P ≤ 0.001). Two patients were found to harbor virus populations with only the R5 phenotype in both compartments, whereas viruses using CXCR4 in addition to CCR5 were detected in two other patients. In particular, one woman harbored genital virus populations with mixed R5 and X4 phenotypes associated with peripheral blood populations with only the R5 phenotype. These results demonstrate genetic compartmentalization of HIV between the plasma and genital secretions of clinically asymptomatic, treatment-naïve, clade A-infected women. Also, for one patient, we report phenotypic coreceptor usage differences between the systemic (R5) and genital (R5/X4) viral populations. These features may be critical for the development of further mucosal vaccines, therapies, or new preventive strategies to block heterosexual transmission.


* Corresponding author. Mailing address: Laboratoire de Virologie, Service de Microbiologie, Hôpital Robert Debré, Avenue du Général Koenig, 51092 Reims Cedex, France. Phone: 33 3 26 78 39 93. Fax: 33 3 26 78 41 34. E-mail: landreoletti{at}chu-reims.fr

{triangledown} Published ahead of print on 25 April 2007.


Journal of Clinical Microbiology, June 2007, p. 1838-1842, Vol. 45, No. 6
0095-1137/07/$08.00+0     doi:10.1128/JCM.00113-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.